Dr. Philip Hyungjin Chang, MD

Dr. Chang practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Chang's NPI, 1134375512, was assigned on August 17, 2008. Dr. Chang graduated from Heersink School of Medicine - Birmingham in 2004. Dr. Chang holds New York license 296023.

Dr. Chang's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Chang's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Chang is also affiliated with Lenox Hill Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Chang to 2 more clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Chang is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Chang's licenses on file in 9 states: New York, Michigan, Florida, Illinois, Massachusetts, California, Ohio, South Carolina and Tennessee.

Dmand AI lists removal of damaged skin or skin graft among the conditions Dr. Chang treats.

CMS data shows 106 Medicare services from Dr. Chang across 3 procedure codes in 2024, for 91 Medicare patients. Medicare paid $11,923 for them.

CMS counts 91 Medicare patients who saw Dr. Chang in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 52, with 53% women.

In 2024, Dr. Chang wrote 54 Medicare Part D claims for 26 patients. 83% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $108 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chang for performance year 2024, reported through an alternative payment model (APM). Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth. CMS counts 13 procedures of removal of tissue by Dr. Chang, more than 64% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Chang, published from 2012 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Burns, RNA, Small Interfering and Parents. Dr. Chang has published most often in J Burn Care Res. Dr. Chang's most frequent co-authors are Jeffrey C. Schneider, MD, Petra M. Warner, MD and Tina L. Palmieri, MD.

CMS Open Payments shows 75 general payments to Dr. Chang from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. PolyNovo North America LLC paid the most, $16,495.

Dmand AI lists 1 award for Dr. Chang.

Dr. Chang graduated from Heersink School of Medicine - Birmingham in 2004. Dr. Chang is a member of ACS.

Dr. Chang is in network with 17 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.